The Tam formula: A pilot study for a new treatment for melasma.
J Cosmet Dermatol
; 20(7): 2168-2171, 2021 Jul.
Article
en En
| MEDLINE
| ID: mdl-33206439
ABSTRACT
BACKGROUND:
Melasma is a common hyperpigmentation disorder with numerous, but often unsatisfactory treatment options.AIMS:
A pilot study to evaluate the efficacy and safety of a novel topical combination of 12% hydroquinone, 6% kojic acid, and 5% vitamin C cream for melasma. PATIENTS ANDMETHODS:
A pilot study of 6 women with melasma was conducted at an academic dermatology department and a private dermatology practice to evaluate the efficacy of a topical combination of 12% hydroquinone, 6% kojic acid, and 5% vitamin C cream, entitled the "Tam Formula." Two blinded evaluators calculated Melasma Area and Severity Index (MASI) Scores before and after treatment to evaluate change from baseline, and statistical analysis was performed.RESULTS:
Treatment with this combination topical cream resulted in an average 63.77 ± 22.10 percent reduction in MASI scores.CONCLUSIONS:
While there is a need for further investigation, this pilot study indicates the Tam Formula may provide an alternative treatment option for melasma.Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Melanosis
Límite:
Female
/
Humans
Idioma:
En
Revista:
J Cosmet Dermatol
Asunto de la revista:
DERMATOLOGIA
Año:
2021
Tipo del documento:
Article
País de afiliación:
Estados Unidos